NIH-funded research R01 grant

Understanding how brain activity relates to epilepsy and its treatment

Official title: Cellular and network mechanisms of epilepsy and neuromodulation

Funded at Boston University (Charles River Campus) · NIH-11129235 · Data updated 2026-11-12

This study is looking at how epilepsy works in the brain and aims to find ways to predict seizures and improve treatment for people who don’t respond to medication, using electrical stimulation to help manage their condition better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University (Charles River Campus)
NIH-funded
Lab location1 site (Boston, United States)
Project startJune 1, 2025
Project endMay 31, 2030
Funding year2025
Award (this year)$657,958
NIH project number1R01NS139524-01A1
Project IDNIH-11129235 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with epilepsy, particularly those who experience drug-resistant seizures.

Less likely to help

Patients with well-controlled epilepsy or those who do not experience seizures may not benefit from this research.

What this research studies

This research investigates the cellular and network mechanisms underlying epilepsy, a serious brain disorder affecting millions. It focuses on identifying specific biomarkers present between seizures that can help predict seizure risk and improve management. The study also explores the effects of neuromodulation through electrical stimulation as a treatment for patients with drug-resistant epilepsy. By combining expertise from various fields, the research aims to uncover the neural mechanisms involved and optimize stimulation parameters for better clinical outcomes.

Why it matters

Potential benefit: If successful, this research could lead to improved prediction and management of seizures, enhancing treatment options for patients with epilepsy.

How similar studies have gone: Previous research has shown promise in identifying biomarkers for epilepsy and the potential of neuromodulation, suggesting that this approach could lead to significant advancements in treatment.

Where this research is happening

  • Boston University (Charles River Campus)
    Boston, United States
    Active

Researchers

  • Principal investigator: Han, Xue — Boston University (Charles River Campus)
  • Study coordinator: Han, Xue

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.